Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
Seiffge
D
D
Department of Pharmacology, Hoechst AG, Werk Albert, Wiesbaden, West Germany.
Weithmann
K U
KU
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001783:Blood Flow Velocity / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004907:Erythrocyte Deformability / Q000187:drug effects*; D006801:Humans; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D008641:Mesenteric Vascular Occlusion / Q000097:blood; D010431:Pentoxifylline / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D013805:Theobromine / Q000031:analogs & derivatives*; D013927:Thrombosis / Q000097:blood
D013805:Theobromine; D001241:Aspirin; D010431:Pentoxifylline